PROT# AST-MHE201: A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy, Safety and Tolerability of AST-120 (Spherical Carbon Adsorbent) for 8 Weeks in the Treatment of Mild Hepatic Encephalopa

Project: Research project

Project Details

StatusFinished
Effective start/end date6/3/09 → 6/3/12

Funding

  • Ocera Therapeutics, Inc (AST-MHE201)